BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 36361758)

  • 1. Old and New Blood Markers in Human Colorectal Cancer.
    Wautier JL; Wautier MP
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of carcinoembryonic antigen combined with cytokines in serum of patients with colorectal cancer.
    Ma Y; Zhang Y; Bi Y; He L; Li D; Wang D; Wang M; Wang X
    Medicine (Baltimore); 2022 Sep; 101(37):e30787. PubMed ID: 36123861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of TEM-8 and CEA tumor markers indicating free tumor cells in the peripheral blood of colorectal cancer patients.
    Raeisossadati R; Farshchian M; Ganji A; Tavassoli A; Velayati A; Dadkhah E; Chavoshi S; Mehrabi Bahar M; Memar B; Rajabi Mashhadi MT; Naseh H; Forghanifard MM; Moghbeli M; Moaven O; Abbaszadegan MR
    Int J Colorectal Dis; 2011 Oct; 26(10):1265-70. PubMed ID: 21573768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CEA in activated macrophages. New diagnostic possibilities for tumor markers in early colorectal cancer.
    Japink D; Leers MP; Sosef MN; Nap M
    Anticancer Res; 2009 Aug; 29(8):3245-51. PubMed ID: 19661342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating epigenetic biomarkers for detection of recurrent colorectal cancer.
    Symonds EL; Pedersen SK; Murray D; Byrne SE; Roy A; Karapetis C; Hollington P; Rabbitt P; Jones FS; LaPointe L; Segelov E; Young GP
    Cancer; 2020 Apr; 126(7):1460-1469. PubMed ID: 31909823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between circulating tumor DNA and carcinoembryonic antigen levels in patients with metastatic colorectal cancer.
    Osumi H; Shinozaki E; Ooki A; Shimozaki K; Kamiimabeppu D; Nakayama I; Wakatsuki T; Ogura M; Takahari D; Chin K; Yamaguchi K
    Cancer Med; 2021 Dec; 10(24):8820-8828. PubMed ID: 34821068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
    Wang JY; Wu CH; Lu CY; Hsieh JS; Wu DC; Huang SY; Lin SR
    World J Surg; 2006 Jun; 30(6):1007-13. PubMed ID: 16736329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients.
    Shimada R; Iinuma H; Akahane T; Horiuchi A; Watanabe T
    Oncol Rep; 2012 Apr; 27(4):947-53. PubMed ID: 22267181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.
    Pesta M; Fichtl J; Kulda V; Topolcan O; Treska V
    Anticancer Res; 2013 May; 33(5):2239-43. PubMed ID: 23645782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunobead multiplex RT-PCR detection of carcinoembryonic genes expressing cells in the blood of colorectal cancer patients.
    Douard R; Moutereau S; Serru V; Sales JP; Wind P; Cugnenc PH; Vaubourdolle M; Loric S
    Clin Chem Lab Med; 2005; 43(2):127-32. PubMed ID: 15843204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor DNA is a sensitive marker for routine monitoring of treatment response in advanced colorectal cancer.
    Zou D; Day R; Cocadiz JA; Parackal S; Mitchell W; Black MA; Lawrence B; Fitzgerald S; Print C; Jackson C; Guilford P
    Carcinogenesis; 2020 Nov; 41(11):1507-1517. PubMed ID: 32955091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancer.
    Hermunen K; Soveri LM; Boisen MK; Mustonen HK; Dehlendorff C; Haglund CH; Johansen JS; Osterlund P
    Acta Oncol; 2020 Dec; 59(12):1416-1423. PubMed ID: 32790589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer.
    Zieglschmid V; Hollmann C; Mannel J; Albert W; Jaeschke-Melli S; Eckstein B; Hillemann T; Greten TF; Gross E; Böcher O
    Anticancer Res; 2007; 27(4A):1823-32. PubMed ID: 17649779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cell enumeration for improved screening and disease detection of patients with colorectal cancer.
    Tsai WS; Hung WS; Wang TM; Liu H; Yang CY; Wu SM; Hsu HL; Hsiao YC; Tsai HJ; Tseng CP
    Biomed J; 2021 Dec; 44(6 Suppl 2):S190-S200. PubMed ID: 35292267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Assessment of Colorectal Cancer by Quantifying Circulating Tumor Cells in Peripheral Blood: ECT2 in Diagnosis of Colorectal Cancer.
    Chen CJ; Sung WW; Chen HC; Chern YJ; Hsu HT; Lin YM; Lin SH; Peck K; Yeh KT
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28362321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
    Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
    BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Comparative Surveillance Strategies of Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen Levels in Patients With Resected Colorectal Cancer.
    Fakih M; Sandhu J; Wang C; Kim J; Chen YJ; Lai L; Melstrom K; Kaiser A
    JAMA Netw Open; 2022 Mar; 5(3):e221093. PubMed ID: 35258578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers.
    Schuster R; Max N; Mann B; Heufelder K; Thilo F; Gröne J; Rokos F; Buhr HJ; Thiel E; Keilholz U
    Int J Cancer; 2004 Jan; 108(2):219-27. PubMed ID: 14639606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.